Limitations to the use of the CA-125 antigen level in ovarian cancer.
Markman
Maurie
M
Department of Hematology/Medical Oncology, The Cleveland Clinic Foundation, R35, 9500 Euclid Avenue, Cleveland, OH 44195, USA. markmam@ccf.org
D014408:Biomarkers, Tumor / Q000032:analysis / Q000097:blood*; D018394:CA-125 Antigen / Q000032:analysis / Q000097:blood*; D005260:Female; D006801:Humans; D008403:Mass Screening / Q000379:methods; D010051:Ovarian Neoplasms / Q000175:diagnosis*; D011379:Prognosis; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen